Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain
It is generally believed that a successful Zika virus (ZIKV) vaccine should induce neutralizing antibodies against the ZIKV envelope (E) protein to efficiently halt viral infection. However, E-specific neutralizing antibodies have been implicated in a phenomenon called antibody-dependent enhancement...
Guardado en:
Autores principales: | Loulieta Nazerai, Søren Buus, Anette Stryhn, Allan Randrup Thomsen, Jan Pravsgaard Christensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f35c58cfd4ae4020b4a0433eafa35e0c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
por: Mark J. Bailey, et al.
Publicado: (2019) -
NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus
por: Samuel Santos Pereira, et al.
Publicado: (2021) -
Zika Virus NS2A-Mediated Virion Assembly
por: Xianwen Zhang, et al.
Publicado: (2019) -
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
por: Zahra Hasanshahi, et al.
Publicado: (2021) -
Reovirus Nonstructural Protein σNS Recruits Viral RNA to Replication Organelles
por: Christopher H. Lee, et al.
Publicado: (2021)